Vivozon Healthcare Inc (KQ:082800) — Market Cap & Net Worth
Market Cap & Net Worth: Vivozon Healthcare Inc (082800)
Vivozon Healthcare Inc (KQ:082800) has a market capitalization of $145.07 Million (₩214.07 Billion) as of September 18, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #17853 globally and #754 in its home market, demonstrating a -7.41% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Vivozon Healthcare Inc's stock price ₩2875.00 by its total outstanding shares 74460304 (74.46 Million). Also see Vivozon Healthcare Inc balance sheet assets for a full breakdown of the balance sheet.
Vivozon Healthcare Inc Market Cap History: 2015 to 2026
Vivozon Healthcare Inc's market capitalization history from 2015 to 2026. Data shows change from $309.07 Million to $145.07 Million (-7.03% CAGR). Also see Vivozon Healthcare Inc cash flow conversion for how efficiently the company converts equity into cash flow.
Index Memberships
Vivozon Healthcare Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$233.34 Billion | 0.06% | #272 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$233.34 Billion | 0.06% | #272 of 1384 |
Weight: Vivozon Healthcare Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Vivozon Healthcare Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Vivozon Healthcare Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check current stock price of Vivozon Healthcare Inc for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.00x
Vivozon Healthcare Inc's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $317.90 Million | $68.21 Billion | -$1.78 Billion | 0.00x | N/A |
| 2017 | $257.35 Million | $61.02 Billion | -$6.67 Billion | 0.00x | N/A |
| 2018 | $363.32 Million | $46.00 Billion | -$8.53 Billion | 0.01x | N/A |
| 2019 | $528.58 Million | $44.95 Billion | -$28.00 Billion | 0.01x | N/A |
| 2020 | $532.36 Million | $43.59 Billion | -$43.75 Billion | 0.01x | N/A |
| 2021 | $276.27 Million | $57.73 Billion | -$69.46 Billion | 0.00x | N/A |
| 2022 | $160.72 Million | $51.56 Billion | -$39.91 Billion | 0.00x | N/A |
| 2023 | $151.38 Million | $71.32 Billion | -$3.36 Billion | 0.00x | N/A |
| 2024 | $347.17 Million | $87.60 Billion | -$9.98 Billion | 0.00x | N/A |
| 2025 | $204.37 Million | $59.34 Billion | -$32.42 Billion | 0.00x | N/A |
Competitor Companies of 082800 by Market Capitalization
Companies near Vivozon Healthcare Inc in the global market cap rankings as of September 18, 2026. Review Vivozon Healthcare Inc tangible equity quality to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Vivozon Healthcare Inc by market ranking:
- Sam Chun Dang Pharm. Co. Ltd (KQ:000250): Ranked #5752 globally with a market cap of $2.26 Billion USD ( ₩3.34 Trillion KRW).
- ST Pharm Co.Ltd (KQ:237690): Ranked #8322 globally with a market cap of $1.14 Billion USD ( ₩1.69 Trillion KRW).
- NatureCell Co.Ltd (KQ:007390): Ranked #9400 globally with a market cap of $895.63 Million USD ( ₩1.32 Trillion KRW).
- Oscotec Inc (KQ:039200): Ranked #10937 globally with a market cap of $654.17 Million USD ( ₩965.30 Billion KRW).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #5752 | Sam Chun Dang Pharm. Co. Ltd | KQ:000250 | $2.26 Billion | ₩156100.00 |
| #8322 | ST Pharm Co.Ltd | KQ:237690 | $1.14 Billion | ₩90400.00 |
| #9400 | NatureCell Co.Ltd | KQ:007390 | $895.63 Million | ₩24900.00 |
| #10937 | Oscotec Inc | KQ:039200 | $654.17 Million | ₩34350.00 |
Vivozon Healthcare Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, Vivozon Healthcare Inc's market cap moved from $309.07 Million to $ 145.07 Million, with a yearly change of -7.03%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩145.07 Million | -29.01% |
| 2025 | ₩204.37 Million | -41.13% |
| 2024 | ₩347.17 Million | +129.33% |
| 2023 | ₩151.38 Million | -5.81% |
| 2022 | ₩160.72 Million | -41.83% |
| 2021 | ₩276.27 Million | -48.10% |
| 2020 | ₩532.36 Million | +0.72% |
| 2019 | ₩528.58 Million | +45.49% |
| 2018 | ₩363.32 Million | +41.18% |
| 2017 | ₩257.35 Million | -19.05% |
| 2016 | ₩317.90 Million | +2.86% |
| 2015 | ₩309.07 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 17th, 2026 the market cap of Vivozon Healthcare Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $145.07 Million USD |
| MoneyControl | $145.07 Million USD |
| MarketWatch | $145.07 Million USD |
| marketcap.company | $145.07 Million USD |
| Reuters | $145.07 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Vivozon Healthcare Inc
Vivozon Pharmaceutical Co., Ltd. researches, develops, produces, and sells LED products primarily in South Korea. The company offers LED packages for interior, general, indoor, decorative, and automotive lighting, as well as display applications. It also provides LED set linear lamps, including panel lamps, down lights, and flood lights for residential, commercial, and industrial structures, as w… Read more